Search Results - "Shabalova, L."

High prevalence of W1282x mutation in cystic fibrosis patients from Karachay-Cherkessia by Petrova, N.V, Kashirskaya, N.Yu, Vasilyeva, T.A, Timkovskaya, E.E, Voronkova, A.Yu, Shabalova, L.A, Kondratyeva, E.I, Sherman, V.D, Novoselova, O.G, Kapranov, N.I, Zinchenko, R.A, Ginter, E.K, Makaov, A.Kh-M, Kerem, B

“…Abstract Cystic fibrosis (CF; OMIM # 219700 ) is a common autosomal recessive disease. The spectrum and frequency of CFTR mutations vary significantly in…”
Get full text

69 Respiratory bacterial pathogens in CF patients of Moscow and Moscow Region: prevalence in children and adults and impact on lung function and nutrition by Amelina, E, Chernyak, A, Krasovskiy, S, Voronkova, A, Kondratieva, E, Kashirskaya, N, Usacheva, M, Sherman, V, Nikonova, V, Chernukha, M.Y, Shabalova, L, Shaginyan, I.A, Kapranov, N, Chuchalin, A

Get full text

258 Survival trends and costs of the treatment in the cystic fibrosis patients from Moscow (retrospective analysis 1993–2013) by Kashirskaya, N, Krasovsky, S, Chernyak, A, Sherman, V, Voronkova, A, Shabalova, L, Nikonova, V, Gorinova, Y, Simonova, O, Amelina, E, Samoilenko, V, Kondratyeva, E, Kapranov, N, Petrova, N, Zinchenko, R

Get full text

WS11.4 The significance of a neonatal screening program in the early diagnosis of cystic fibrosis by Sherman, V, Kashirskaya, N, Kapranov, N, Kondrateva, E, Petrova, N, Voronkova, A, Shabalova, L, Nikonova, V, Krasovskiy, S, Cherniak, A, Amelina, E

“…Objectives A national newborn screening (NBS) program for cystic fibrosis (CF) was introduced all over Russia in January 2007. Currently, this is the main…”
Get full text

307 Cystic Fibrosis Patient Registry of Moscow and Moscow Region (CFPRMMO) in 2010–2012 by Amelina, E, Krasovsky, A, Voronkova, A, Cherniak, A, Gorinova, Y, Kashirskaya, N, Kondratieva, E, Nikonova, V, Shabalova, L, Shelepneva, N, Sherman, V, Simonova, O, Usacheva, M, Kapranov, N, Chuchalin, A

“…Objective To compare the data describing demographic characteristics of the patients, survival rates, pulmonary function, microbiologic data, complication…”
Get full text

ePS01.3 Genotype–phenotype correlation in Russian cystic fibrosis patients with S466X–R1070Q complex allele by Petrova, N, Kashirskaya, N, Zinchenko, R, Timkovskaya, E, Voronkova, A, Krasovskiy, S, Shabalova, L, Kondrateva, E, Amelina, E, Sherman, V, Cherniak, A, Kapranov, N

“…In the databases of CFTR mutations (CFTR1 and CFTR2) mutations S466X and R1070Q are described as separate ones: mutation S466X (p.Ser466X, c.1397C>G) – CF…”
Get full text

224 Nutritional status of patients with cystic fibrosis in Russia by Krasovskiy, S, Amelina, E, Kondratyeva, E, Cherniak, A, Voronkova, A, Sherman, V, Kashirskaya, N, Kapranov, N, Shabalova, L, Nikonova, V, Asherova, I, Boitsova, E, Brisin, V, Khachiyan, M, Chikunov, V, Ilenkova, N, Golubtsova, O, Kondakova, J, Kozireva, L, Protasova, T, Skachkova, M, Rybalkina, M, Safonova, T, Merzlova, N, Shadrina, V, Nazarenko, L, Smirnova, I, Sergienko, D, Vasileva, T

“…Objectives To access the nutritional status of cystic fibrosis patients in Russia in the perspective of preventive measures’ development. Methods Nutritional…”
Get full text

298 Establishment of a Russian cystic fibrosis patient registry by Krasovskiy, S, Kashirskaya, N, Kapranov, N, Cherniak, A, Amelina, E, Kondrateva, E, Asherova, I, Boitsova, E, Brisin, V, Chikunov, V, Golubtsova, O, Ilenkova, N, Khachiyan, M, Kondakova, Y, Kozireva, L, Nikonova, V, Protasova, T, Rybalkina, M, Safonova, T, Sergienko, D, Shabalova, L, Shadrina, V, Shelepneva, N, Sherman, V, Smirnova, I, Uspenskaya, I, Vasileva, T, Voronkova, A, Chuchalin, A

Get full text

THE NATIONAL CONSENSUS PROJECT «CYSTIC FIBROSIS: DEFINITION, DIAGNOSTIC CRITERIA, AND THERAPY». SECTION «INHALATION THERAPY» (ABRIDGED) by Amelina, Ye. L., Asherova, I. K., Volkov, I. K., Gembitskaya, Т. Ye, Ginter, Ye. K., Il’yenkova, N. А., Kapranov, N. I., Karimova, I. P., Kashirskaya, N. Yu, Kondrat’yeva, Ye. I., Kostyleva, М. N., Krasovsky, S. А., Merzlova, N. B., Nazarenko, L. P., Namazova-Baranova, L. S., Neretina, А. F., Nikonova, V. S., Orlov, А. V., Postnikov, S. S., Protasova, Т. А., Semykin, S. Yu, Sergienko, D. F., Simonova, О. I., Uspenskaya, I. D., Chernukha, М. Yu, Shabalova, L. А., Shaginyan, I. А., Sherman, V. D.

“…The pulmonary drug administration for the treatment of a pulmonary affection in cystic fibrosis is highly effective. This consensus document summarizes data on…”
Get full text

INFLUENCE OF NEONATAL SCREENING FOR CYSTIC FIBROSIS BY THE EXAMPLE OF PATIENTS OF THE MOSCOW REGION by V. D. Sherman, E. I. Kondratieva, A. Y. Voronkova, N. Y. Kashirskaya, L. A. Shabalova, V. S. Nikonova, E. K. Zhekaite, S. I. Kutsev

“…Study objective: comparative evaluation of clinical status of patients with cystic fibrosis (CF) 6–9 years, the diagnosis of which was established before the…”
Get full text

MICROFLORA OF THE RESPIRATORY TRACT IN PATIENTS WITH CYSTIC FIBROSIS AND SENSITIVITY TO ANTIBIOTICS BASED ON A 15-YEAR FOLLOW-UP (2000–2015 YEARS) by S. V. POLIKARPOVA, E. I. KONDRATYEVA, L. A. SHABALOVA, N. V. PIVKINA, S. V. ZHILINA, A. Y. VORONKOVA, V. D. SHERMAN, V. S. NIKONOVA, N. I. KAPRANOV, N. Y. KASHIRSKAYA, S. Y. SEMYKIN, E. L. AMELINA, S. A. KRASOVSKY

“…Chronic lower respiratory tract infection in patients with cystic fibrosis (CF) is the major factor determining the severity of the clinical course and…”
Get full text

Trends in Life Expectancy of Cystic Fibrosis Patients in Moscow and their Connection with the Treatment Received: Retrospective Analysis for 1993–2013 by Kashirskaya, N. Yu, Krasovsky, S. A., Chernyak, A. V., Sherman, V. D., Voronkova, A. Yu, Shabalova, L. A., Nikonova, V. S., Gorinova, Yu. V., Simonova, O. I., Amelina, E. L., Kondrat’eva, E. I., Kapranov, N. I., Petrova, N. V., Zinchenko, R. A.

“…Cystic fibrosis is multiple organ pathology that requires a complex treatment. Its standardization and pharmacoeconomic analysis are absolutely necessary. We…”
Get full text

Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection by Pukhalsky, A L, Kapranov, N I, Kalashnikova, E A, Shmarina, G V, Shabalova, L A, Kokarovtseva, S N, Pukhalskaya, D A, Kashirskaja, N J, Simonova, O I

“…CHRONIC endobronchial inflammation and bacterial infection are the main causes of morbidity and mortality in cystic fibrosis (CF), an autosomal recessive…”
Get full text

P010 The efficiency of CF newborn screening for homozygous F508del patients by Sherman, V., Kondrateva, E., Voronkova, A., Kashirskaya, N., Zhekayte, E., Shabalova, L.

Get full text

CLINICAL AND GENETIC, MICROBIOLOGICAL AND FUNCTIONAL CHARACTERISTICS OF MOSCOW AND MOSCOW REGION PATIENTS WITH CYSTIC FIBROSIS by Krasovskii, S. A., Nikonova, V. S., Kashirskaya, N. Yu, Kondrat'eva, E. I., Chernyak, A. V., Kapranov, N. I., Amelina, E. L., Sherman, V. D., Samoilenko, V. A., Voronkova, A. Yu, Shabalova, L. A., Simonova, O. I., Usacheva, M. V., Chernikov, V. V.

“…The aim of this study was to assess different clinical and genetic, microbiological and functional features of patients with cystic fibrosis living in Moscow…”
Get full text

Tumor necrosis factor-alpha/interleukin-10 balance in normal and cystic fibrosis children by Shmarina, G V, Pukhalsky, A L, Kokarovtseva, S N, Pukhalskaya, D A, Shabalova, L A, Kapranov, N I, Kashirskaja, N J

“…The balance between tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) is important for immune homeostasis maintenance. Exuberant production of…”
Get full text

P201 Features of somatic growth of children with CF in different age periods in the Russian Federation by Maksimysheva, T., Kondratyeva, E., Voronkova, A., Melyanovskaya, Y., Sherman, V., Zhekayte, E., Chernyak, A., Nazarenko, L., Odinokova, O., Smirnova, I., Mukhacheva, V., Nikonova, V., Shabalova, L., Gorinova, Y., Simonova, O., Usacheva, M., Zonenko, O., Semykin, S., Mukhina, M., Lavrova, A., Erzutova, M., Baykova, G., Kozyreva, L., Boytsova, E., Moskvina, D., Stepanenko, T., Gembitskaya, T., Amelina, E., Kashirskaya, N., Krasovsky, S.

Get full text

Outcomes of the long-term treatment with a novel mucolytic drug pulmozin in mucoviscidosis patients by Kapranov, N I, Gembitskaia, T E, Simonova, O I, Amelina, E L, Kovaleva, L F, Shabalova, L A, Kashirskaia, N Iu, Faustova, M E

“…To study clinical effectiveness and safety of a new mucolytic drug pulmozim (Switzerland) adjuvant to basic therapy in mucoviscidosis patients of different age…”
Get more information

Antibiotic therapy of cystic fibrosis in children by Kapranov, N I, Shabalova, L A, Kashirskaia, N Iu, SimonovaO, O I, Voronkova, A Iu, Osipova, I A, Semykin, S Iu, Polikarpova, S V, Postnikov, S S

“…It is postulated that P. aeruginosa in monoculture or in association with Staphylococcus aureus keeps its leading position in chronic bacterial inflammatory…”
Get more information

Immunologic monitoring of patients with cystic fibrosis: value of different laboratory findings by Pevnitskiĭ, L A, Pukhal'skiĭ, A L, Kapranov, N I, Kalashnikova, E A, Shmarina, G V, Pukhal'skaia, D A, Kokarovtseva, S N, Kashirskaia, N Iu, Shabalova, L A

“…Cystic fibrosis (CF) is a common, serious, and frequently fatal autosomal recessive genetic disorder associated with the poor function of chloride channels…”
Get more information